IBT is committed to using advanced digital methods for the screening and treatment of a range of neurological diseases.Based on software, digital therapeutics is used for intervention targeting specific brain functions.
Collaborating with national key laboratories and top specialized hospitals, IBT conducts long-term scientific research and clinical experiments, developing and providing proprietary digital therapeutic products that have been clinically validated.
Having deep understanding of the patient and family difficulties, IBT strives to improve patient care with products that have higher efficacy and lower cost.